In-vivo biodegradation of extruded lipid implants in rabbits

Journal of Controlled Release

Volumn 163, Issue 2, 2012, Pages 195-202

  Sax, Gerhard ^a   Kessler, Barbara ^a   Wolf, Eckhard ^a   Winter, Gerhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biodegradation; Extrusion; In vivo; Lipid implants; Triglyceride

Indexed keywords

ACCELERATED DEGRADATION; BODY TEMPERATURE; DEGRADABILITY; DEGRADATION PROCESS; EROSION BEHAVIOR; HIGHER MELTING POINTS; IN-VITRO; IN-VIVO; LOW MELTING; MASS LOSS; MATRIX MATERIALS; PARTIAL MELTING; PORE-FORMING AGENTS; POROUS IMPLANTS; RABBIT MODELS; TIME DEPENDENT; TRIGLYCERIDE;

DEGRADATION; DIFFERENTIAL SCANNING CALORIMETRY; EXTRUSION; MICROBIOLOGY; PHASE TRANSITIONS; SCANNING ELECTRON MICROSCOPY;

BIODEGRADATION;

LIPID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIODEGRADATION; BODY FLUID; BODY TEMPERATURE; CHEMICAL REACTION; DEGRADATION KINETICS; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; IMPLANT; IN VIVO STUDY; LIPOLYSIS; MASS; MELTING POINT; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS; THERMOGRAPHY; TWIN SCREW EXTRUSION;

ANIMALS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG IMPLANTS; MICROSCOPY, ELECTRON, SCANNING; RABBITS; TRIGLYCERIDES;

EID: 84866726476     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.08.026     Document Type: Article

References (30)

1. D. Bodmer, T. Kissel, and E. Traechslin Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems J. Control. Release 21 1992 129 137
2. R.A. Siegel, J. Kost, and R. Langer Mechanistic studies of macromolecular drug release from macroporous polymers. I. Experiments and preliminary theory concerning completeness of drug release J. Control. Release 8 1989 223 236 (Pubitemid 19099001)
3. T. Estey, J. Kang, S.P. Schwendeman, and J.F. Carpenter BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems J. Pharm. Sci. 95 2006 1626 1639 (Pubitemid 44049129)
4. A. Brunner, K. Mäder, and A. Göpferich pH and osmotic pressure inside biodegradable microspheres during erosion Pharm. Res. 16 1999 847 853 (Pubitemid 29284195)
5. A. Lucke, and A. Göpferich Acylation of peptides by lactic acid solutions Eur. J. Pharm. Biopharm. 55 2003 27 33 (Pubitemid 36120492)
6. F. Kreye, F. Siepmann, and J. Siepmann Lipid implants as drug delivery systems Expert Opin. Drug Deliv. 5 2008 291 307 (Pubitemid 351454379)
7. M. Schwab, B. Kessler, E. Wolf, G. Jordan, S. Mohl, and G. Winter Correlation of in vivo and in vitro release data for rh-INF[alpha] lipid implants Eur. J. Pharm. Biopharm. 70 2008 690 694
8. M.Z.I. Khan, I.G. Tucker, and J.P. Opdebeeck Cholesterol and lecithin implants for sustained release of antigen: release and erosion in vitro, and antibody response in mice Int. J. Pharm. 76 1991 161 170
9. S. Allababidi, and J.C. Shah Efficacy and pharmacokinetics of site-specific cefazolin delivery using biodegradable implants in the prevention of post-operative wound infections Pharm. Res. 15 1998 325 333 (Pubitemid 28144248)
10. S. Koennings, A. Sapin, T. Blunk, P. Menei, and A. Goepferich Towards controlled release of BDNF - manufacturing strategies for protein-loaded lipid implants and biocompatibility evaluation in the brain J. Control. Release 119 2007 163 172 (Pubitemid 46754504)
11. S. Mohl, and G. Winter Continuous release of rh-interferon &agr;-2a from triglyceride implants: storage stability of the dosage forms Pharm. Dev. Technol. 11 2006 103 110
12. S. Schulze, and G. Winter Lipid extrudates as novel sustained release systems for pharmaceutical proteins J. Control. Release 134 2009 177 185
13. Z.-h. Gao, W.R. Crowley, A.J. Shukla, J.R. Johnson, and J.F. Reger Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: <i>in vivo</i> evaluation Pharm. Res. 12 1995 864 868
14. W. Tian, S. Schulze, M. Brandl, and G. Winter Vesicular phospholipid gel-based depot formulations for pharmaceutical proteins: development and in vitro evaluation J. Control. Release 142 2010 319 325
15. J.P. Opdebeeck, and I.G. Tucker A cholesterol implant used as a delivery system to immunize mice with bovine serum albumin J. Control. Release 23 1993 271 279 (Pubitemid 23063453)
16. P.Y. Wang Lipids as excipient in sustained release insulin implants Int. J. Pharm. 54 1989 223 230
17. C. Guse, S. Koennings, A. Maschke, M. Hacker, C. Becker, S. Schreiner, T. Blunk, T. Spruss, and A. Goepferich Biocompatibility and erosion behavior of implants made of triglycerides and blends with cholesterol and phospholipids Int. J. Pharm. 314 2006 153 160
18. P.Y. Wang Palmitic acid as an excipient in implants for sustained release of insulin Biomaterials 12 1991 57 62
19. W. Vogelhuber, E. Magni, M. Mouro, T. Spruss, C. Guse, A. Gazzaniga, and A. Göpferich Monolithic triglyceride matrices: a controlled-release system for proteins Pharm. Dev. Technol. 8 2003 71 79 (Pubitemid 36337480)
20. S. Koennings, E. Garcion, N. Faisant, P. Menei, J.P. Benoit, and A. Goepferich In vitro investigation of lipid implants as a controlled release system for interleukin-18 Int. J. Pharm. 314 2006 145 152
21. S. Mohl, and G. Winter Continuous release of rh-interferon [alpha]-2a from triglyceride matrices J. Control. Release 97 2004 67 78 (Pubitemid 38624510)
22. M. Schwab, G. Sax, S. Schulze, and G. Winter Studies on the lipase induced degradation of lipid based drug delivery systems J. Control. Release 140 2009 27 33
23. W. Jiskoot, T.W. Randolph, D.B. Volkin, C.R. Middaugh, C. Schöneich, G. Winter, W. Friess, D.J.A. Crommelin, and J.F. Carpenter Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release J. Pharm. Sci. 101 2012 946 954
24. M. Eisenblatter, J. Ehrchen, G. Varga, C. Sunderkotter, W. Heindel, J. Roth, C. Bremer, and A. Wall In vivo optical imaging of cellular inflammatory response in granuloma formation using fluorescence-labeled macrophages J. Nucl. Med. 50 2009 1676 1682
25. K. Vyacheslav, S. Shoham, M. Victoria, L. Kfir, H. Sharon, L. Tsvee, B. Alexander, and H. Alon Use of lipophilic near-infrared dye in whole-body optical imaging of hematopoietic cell homing J. Biomed. Opt. 11 2006 050507
26. J. Chen, I.R. Corbin, H. Li, W. Cao, J.D. Glickson, and G. Zheng Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo J. Am. Chem. Soc. 129 2007 5798 5799 (Pubitemid 46748467)
27. J.M. Anderson In vivo biocompatibility of implantable delivery systems and biomaterials Eur. J. Pharm. Biopharm. 40 1994 1 8 (Pubitemid 24089478)
28. I. Metzmacher Enzymatic Degradation and Drug Release Behavior of Dense Collagen Implants 2005 pp. No pp given
29. J. Hilborn, and L.M. Bjursten A new and evolving paradigm for biocompatibility J. Tissue Eng. Regen. Med. 1 2007 110 119
30. N. Garti, and K. Sato Crystallization and Polymorphism of Fats and Fatty Acids 1988 Marcel Dekker Inc.